Effects of Serotonin, GABA, and Bone Marrow Cells on Parkinson's Disease in Rats
Author Information
Author(s): Nandhu MS, Paul Jes, Kuruvilla Korah P, Malat Anitha, Romeo Chinthu, Paulose CS
Primary Institution: Cochin University of Science and Technology
Hypothesis
The study investigates the effects of serotonin, GABA, and bone marrow cell supplementation on glutamate activity in a rat model of Parkinson's disease.
Conclusion
The combination of serotonin, GABA, and bone marrow cells significantly reversed biochemical and behavioral abnormalities in Parkinson's disease rats.
Supporting Evidence
- 6-OHDA infusion significantly decreased dopamine content in the cerebral cortex.
- Combinational treatment with serotonin, GABA, and bone marrow cells reversed dopamine levels to near control.
- Gene expression studies showed significant changes in NMDA2B, mGluR5, and GLAST in treated rats.
- Behavioral studies confirmed the biochemical findings, showing improved motor function.
Takeaway
Researchers found that giving certain brain chemicals and cells to sick rats helped them feel better and act more normally.
Methodology
The study used adult male Wistar rats, divided into groups, and treated them with 6-OHDA, serotonin, GABA, and bone marrow cells, followed by behavioral and biochemical assessments.
Potential Biases
Potential bias in the selection of treatment groups and the interpretation of behavioral results.
Limitations
The study was conducted on a specific rat model, which may not fully represent human Parkinson's disease.
Participant Demographics
Adult male Wistar rats, weighing 250-300 g.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website